TrialBritish journal of clinical pharmacology2013

An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.

Klaus Schaffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.